Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Q-linea AB's Days Inventory or its related term are showing as below:
OSTO:QLINEA'
s Days Inventory Range Over the Past 10 Years
Min: 140.66 Med: 645.06 Max: 4704.63
Current: 1420.25
During the past 11 years, Q-linea AB's highest Days Inventory was 4704.63. The lowest was 140.66. And the median was 645.06.
OSTO:QLINEA's Days Inventory is ranked worse than 97.58% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs OSTO:QLINEA: 1420.25
Q-linea AB's Days Inventory
declined
from Jun. 2025 (1,032.02) to Jun. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Q-linea AB's Inventory Turnover for the
three
months ended in Jun. 2026 was -0.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Q-linea AB's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 18.79.
Q-linea AB (OSTO:QLINEA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Q-linea AB's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Q-linea AB's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Q-linea AB Days Inventory Related Terms
Q-linea AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Q-linea AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLINEA vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Q-linea AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-linea AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Q-linea AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-linea AB (OSTO:QLINEA) has a Days Inventory of 0.00 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Q-linea AB and its competitors. Over the past decade, Q-linea AB's Days Inventory has ranged from 140.66 to 4,704.63. According to the industry distribution chart, Q-linea AB ranks #767 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 97.6%.
Is Q-linea AB's Days Inventory too high?
Q-linea AB's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 140.66 to a high of 4,704.63. Based on the distribution chart, Q-linea AB ranks #767 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Q-linea AB has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-linea AB ranks #767 out of 786 companies for Days Inventory. This places Q-linea AB in the lower half of its industry. The industry median Days Inventory is 179.60. Historically, Q-linea AB's own Days Inventory has ranged from 140.66 to 4,704.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Q-linea AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q-linea AB's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Based on GuruFocus' analysis, Q-linea AB (OSTO:QLINEA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr19.67, compared to a current price of kr17.05 — trading 13.3% below its estimated fair value. The current Days Inventory is 0.00. Q-linea AB's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Q-linea AB (OSTO:QLINEA), the current Days Inventory is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?
Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued.
The current stock price of kr17.05 is trading 13.3% below its estimated GF Value™ of kr19.67.
GuruFocus considers Q-linea AB to be Modestly Undervalued.
Key valuation signals for OSTO:QLINEA:
Days Inventory: 0.00
GF Value™: kr19.67 vs. price of kr17.05 (13.3% below fair value)
No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
65GF Score
Get the complete analysis for OSTO:QLINEA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLINEA has been successfully added to your 
